Are We Moving Away from Cystectomy for Bladder Cancer? The Art and Science of Selection
By: Arlene O. Siefker-Radtke, MD
NGS Molecular Testing in Blood vs Tissue? How About in Other Biospecimens?
By: Arnab Basu, MD, MPH, FACP
PARP Inhibitors in Earlier Stages of Prostate Cancer- Current Data & Future Directions.pdf
By: Benjamin Maughan, MD, PharmD
Prostate and Bladder Cancers: What Have we Learned Over the Past Year?
By: Chandler H. Park, MD, MSc, FACP
